Breaking News Instant updates and real-time market news.

2022-07-07 08:42:02 PPL PPL Corp. $27.04 / +0.23 (+0.86%) 08:42 07/07/22 07/07 08:42 07/07/22 08:42	PPL Corp. upgraded to Outperform at Evercore ISI with re-rating expected Evercore ISI analyst Durgesh Chopra upgraded PPL Corp. to Outperform from In Line with a price target of $30, down from $31. Following a restructuring, selling its UK business last June 14 and using part of the proceeds to acquire a Rhode Island based utility this May, he believes the shares should command a higher valuation than currently reflected in the stock and are "ripe for a re-rate," Chopra tells investors. With minimal regulatory risk until 2025, no equity issuance, and "a much simpler execution story," he expects PPL shares to benefit from incremental investor interest in a volatile market, the analyst added.

2022-07-07 08:42:02

PPL

PPL Corp.

$27.04 / +0.23 (+0.86%)

08:42

07/07/22

07/07

08:42

07/07/22

08:42

PPL Corp. upgraded to Outperform at Evercore ISI with re-rating expected

Evercore ISI analyst Durgesh Chopra upgraded PPL Corp. to Outperform from In Line with a price target of $30, down from $31. Following a restructuring, selling its UK business last June 14 and using part of the proceeds to acquire a Rhode Island based utility this May, he believes the shares should command a higher valuation than currently reflected in the stock and are "ripe for a re-rate," Chopra tells investors. With minimal regulatory risk until 2025, no equity issuance, and "a much simpler execution story," he expects PPL shares to benefit from incremental investor interest in a volatile market, the analyst added.

OTHER BREAKING NEWS FROM THE FLY

Recommendations	Quoin Pharmaceuticals price target lowered to $10 from $25 at Maxim » 08:20 08/19/22 08/19 08:20 08/19/22 08:20 QNRX Quoin Pharmaceuticals $4.89 / -0.495 (-9.20%) Maxim analyst Naz Rahman… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly QNRX Quoin Pharmaceuticals $4.89 / -0.495 (-9.20%) 08/05/22 Cellect Biotechnology Ltd - ADR trading resumes 08/05/22 Cellect Biotechnology Ltd - ADR trading halted, volatility trading pause 08/04/22 Cellect Biotechnology Ltd - ADR trading resumes 08/04/22 Cellect Biotechnology Ltd - ADR trading halted, volatility trading pause QNRX Quoin Pharmaceuticals $4.89 / -0.495 (-9.20%) 05/06/22 Ladenburg Ladenburg starts Quoin Pharmaceuticals at Buy with $2 price target 05/06/22 Ladenburg Quoin Pharmaceuticals initiated with a Buy at Ladenburg 01/07/22 Maxim Quoin Pharmaceuticals initiated with a Buy at Maxim 01/07/22 Maxim Quoin Pharmaceuticals initiated with a Buy at Maxim QNRX Quoin Pharmaceuticals $4.89 / -0.495 (-9.20%) 08/18/22 Quoin Pharmaceuticals reports Q2 EPS ($3.24) vs. ($18.05) last year QNRX Quoin Pharmaceuticals $4.89 / -0.495 (-9.20%) 05/06/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
Hot Stocks	Wayfair announces workforce reduction involving 870 employees » 08:16 08/19/22 08/19 08:16 08/19/22 08:16 W Wayfair $71.34 / +1.88 (+2.71%) In a regulatory filing,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options W Wayfair $71.34 / +1.88 (+2.71%) 06/28/22 J.B. Hunt, Waymo add Wayfair to autonomous trucking pilot in Texas 05/05/22 Wayfair falls -19.3% 05/05/22 Wayfair falls -20.0% 05/05/22 Wayfair falls -17.9% W Wayfair $71.34 / +1.88 (+2.71%) 08/05/22 Wedbush Wayfair price target raised to $60 from $50 at Wedbush 08/05/22 Credit Suisse Wayfair price target lowered to $150 from $195 at Credit Suisse 08/05/22 Barclays Wayfair price target lowered to $50 from $57 at Barclays 08/04/22 Stifel Wayfair price target raised to $60 from $55 at Stifel W Wayfair $71.34 / +1.88 (+2.71%) 08/04/22 Wayfair sees Q3 revenue below Q2, consensus $3.11B 08/04/22 Wayfair reports Q2 EPS $1.94 vs. $1.89 last year 08/03/22 Notable companies reporting before tomorrow's open 08/03/22 Notable companies reporting before tomorrow's open W Wayfair $71.34 / +1.88 (+2.71%) 05/17/22 Wayfair freezes hiring for 90 days due to uncertainty, Bloomberg says W Wayfair $71.34 / +1.88 (+2.71%) 08/04/22 Fly Intel: Pre-market Movers 08/02/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 06/21/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 05/27/22 Sell these stocks now, proven algorithm says W Wayfair $71.34 / +1.88 (+2.71%) 08/18/22 Wayfair call volume above normal and directionally bullish 08/04/22 Unusually active option classes on open August 4th 08/02/22 Wayfair put volume heavy and directionally bearish 07/28/22 Wayfair put volume heavy and directionally bearish
Earnings	Goodbody Health reports 1H revenue C$12.22M vs. C$8.01M last year » 08:11 08/19/22 08/19 08:11 08/19/22 08:11 GDBYF Goodbody Health / + The company said,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Earnings GDBYF Goodbody Health / + 08/10/22 Goodbody Health provides update on annual general, special meeting 07/14/22 Goodbody Health announces Annual General, Special Meeting of Shareholders 06/16/22 Goodbody Health granted Care Quality Commission registration 06/10/22 Goodbody Health announces intention to delist from CSE GDBYF Goodbody Health / + 05/25/22 Goodbody Health reports Q1 revenue GBP 5.17M vs. GBP 1.38M last year 03/10/22 Goodbody Health sees 2021 revenue C$29M
Recommendations	Nice price target raised to $275 from $260 at JPMorgan » 08:11 08/19/22 08/19 08:11 08/19/22 08:11 NICE Nice $224.68 / -3.66 (-1.60%) JPMorgan analyst Paul… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings NICE Nice $224.68 / -3.66 (-1.60%) 06/08/22 Nice Actimize Xceed AI cloud platform chosen by American State Bank 04/13/22 Nice's CXOne portfolio adopted by Deutsche Telekom Global Business NICE Nice $224.68 / -3.66 (-1.60%) 07/26/22 Barclays Nice price target lowered to $283 from $356 at Barclays 05/13/22 RBC Capital Nice price target lowered to $240 from $365 at RBC Capital 05/12/22 Jefferies Nice price target lowered to $225 from $260 at Jefferies 02/18/22 Citi Nice price target lowered to $306 from $314 at Citi NICE Nice $224.68 / -3.66 (-1.60%) 08/18/22 Nice raises FY22 adjusted EPS view to $7.33-$7.53 from $7.25-$7.45 08/18/22 Nice sees Q3 adjusted EPS $1.82-$1.92, consensus $1.84 08/18/22 Nice reports Q2 adjusted EPS $1.86, consensus $1.79 05/12/22 Nice raises FY22 adjusted EPS view to $7.25-$7.45 from $7.07-$7.27
Syndicate	Capstone Green Energy 2.9M share Spot Secondary priced at $2.75 » 08:11 08/19/22 08/19 08:11 08/19/22 08:11 CGRN Capstone Green Energy $3.94 / +0.29 (+7.95%) Lake Street acted as lead… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Syndicate Events CGRN Capstone Green Energy $3.94 / +0.29 (+7.95%) 08/17/22 Capstone secures order for five C1000 Signature Series microturbines 08/09/22 Capstone Green Energy to provide1.2 MW of microturbine energy systems in CA 08/03/22 Capstone Green Energy secures follow-on order for C200S microturbine systems 08/01/22 Capstone Green Energy secures order for 200 kW microturbine-based system 19 Aug 09/14/22 6th Annual Best Ideas Growth Conference: Big 6 09/12/22 Capstone Green Energy Corp.
Hot Stocks	Mobile Global Esports details upcoming 2022/2023 collegiate tournament season » 08:10 08/19/22 08/19 08:10 08/19/22 08:10 MGAM Mobile Global Esports $3.79 / -0.02 (-0.52%) Mobile Global Esports… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Syndicate On The Fly MGAM Mobile Global Esports $3.79 / -0.02 (-0.52%) 08/10/22 Mobile Global Esports enters exclusive compression technology partnership 08/04/22 Mobile Global Esports Inc trading resumes 08/04/22 Mobile Global Esports Inc trading halted, volatility trading pause 08/02/22 Mobile Global Esports Inc trading resumes 29 Jul MGAM Mobile Global Esports $3.79 / -0.02 (-0.52%) 07/30/22 Opening Day: Immune-oncology company MAIA Biotechnology drops in market debut
Recommendations	Applied Materials price target lowered to $140 from $158 at JPMorgan » 08:10 08/19/22 08/19 08:10 08/19/22 08:10 AMAT Applied Materials $108.28 / +2.42 (+2.29%) JPMorgan analyst Harlan… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options AMAT Applied Materials $108.28 / +2.42 (+2.29%) 06/16/22 Applied Materials acquires Picosun Oy, terms not disclosed 05/26/22 Applied Materials introduces new Ioniq PVD System 04/21/22 Applied Materials introduces technologies enabling 2D scaling with EUV 04/14/22 Worldwide semiconductor revenue grew 26% in 2021, Gartner says AMAT Applied Materials $108.28 / +2.42 (+2.29%) 07:53 Today DA Davidson Applied Materials price target lowered to $155 from $170 at DA Davidson 07:37 Today Cowen Applied Materials price target lowered to $140 from $160 at Cowen 07:09 Today Stifel Applied Materials price target lowered to $184 from $197 at Stifel 07:08 Today Deutsche Bank Applied Materials price target raised to $115 from $110 at Deutsche Bank AMAT Applied Materials $108.28 / +2.42 (+2.29%) 08/18/22 Applied Materials sees Q4 EPS $1.82-$2.18, consensus $1.94 08/18/22 Applied Materials reports Q3 EPS $1.94, consensus $1.79 08/18/22 Notable companies reporting after market close 05/19/22 Applied Materials sees Q3 adjusted EPS $1.59-$1.95, consensus $2.04 AMAT Applied Materials $108.28 / +2.42 (+2.29%) 07/27/22 Senate pushes bipartisan chip bill to House to boost U.S, production, CNN says 05/09/22 U.S. considering broader crackdown on Chinese chipmakers, Information reports AMAT Applied Materials $108.28 / +2.42 (+2.29%) 08/18/22 Fly Intel: After-Hours Movers 06/30/22 Here's what Wall Street is saying about Micron ahead of earnings 05/20/22 What You Missed On Wall Street On Friday 05/20/22 What You Missed On Wall Street This Morning AMAT Applied Materials $108.28 / +2.42 (+2.29%) 08/18/22 Applied Materials options imply 3.8% move in share price post-earnings 07/26/22 Applied Materials put volume heavy and directionally bearish 05/19/22 Applied Materials options imply 6.3% move in share price post-earnings 05/19/22 Unusually active option classes on open May 19th
Hot Stocks	Grom Social's Curiosity Ink Media debuts Baldwin franchise » 08:08 08/19/22 08/19 08:08 08/19/22 08:08 GROM Grom Social Enterprises / + Grom Social Enterprises… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research GROM Grom Social Enterprises / + 08/17/22 Grom Social's Top Draw Animation secures $1.3M in assignments 07/27/22 Grom Social Enterprises CEO issues letter to shareholders 07/20/22 Grom Educational Services rolls out updated Digital Citizenship Licensing course 07/12/22 Curiosity Ink Media to debut 'The Legion of Forgettable Supervillians' GROM Grom Social Enterprises / + 07/26/22 EF Hutton Grom Social price target lowered to $2 from $5 at EF Hutton 01/13/22 EF Hutton Grom Social Enterprises initiated with a Buy at EF Hutton
Recommendations	Bill.com price target raised to $222 from $200 at JPMorgan » 08:08 08/19/22 08/19 08:08 08/19/22 08:08 BILL Bill.com $149.71 / -1.85 (-1.22%) JPMorgan analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Options BILL Bill.com $149.71 / -1.85 (-1.22%) 08/18/22 Bill.com names Sofya Pogreb COO 08/15/22 Lone Pine buys Booking, exits Snap in Q2 07/20/22 Bill.com CFO sells $3.8M in common stock 05/19/22 Bill.com rises 16.6% BILL Bill.com $149.71 / -1.85 (-1.22%) 07:06 Today Deutsche Bank Bill.com price target raised to $240 from $177 at Deutsche Bank 06:07 Today Piper Sandler Bill.com price target raised to $215 from $170 at Piper Sandler 05:55 Today KeyBanc Bill.com price target raised to $200 from $150 at KeyBanc 04:57 Today Keefe Bruyette Bill.com price target raised to $269 from $245 at Keefe Bruyette BILL Bill.com $149.71 / -1.85 (-1.22%) 08/18/22 Bill.com sees FY23 adjusted EPS 23c-38c, consensus (34c) 08/18/22 Bill.com sees Q1 adjusted EPS 5c-7c, consensus (9c) 08/18/22 Bill.com reports Q4 adjusted EPS (3c), consensus (13c) 05/05/22 Bill.com sees FY22 EPS (35c)-(34c), consensus (46c) 22 Sep BILL Bill.com $149.71 / -1.85 (-1.22%) 08/18/22 Fly Intel: After-Hours Movers 06/12/22 Sell these stocks now, proven algorithm says 06/03/22 Sell these stocks now, proven algorithm says 05/20/22 What You Missed On Wall Street On Friday BILL Bill.com $149.71 / -1.85 (-1.22%) 08/18/22 Bill.com Holdings options imply 11.0% move in share price post-earnings 05/12/22 Bill.com Holdings put volume heavy and directionally bearish 05/05/22 Bill.com Holdings options imply 14.0% move in share price post-earnings
Recommendations	Ayr Wellness price target lowered to $10 from $14 at Northland » 08:08 08/19/22 08/19 08:08 08/19/22 08:08 AYRWF Ayr Wellness $4.40 / -0.13675 (-3.01%) Northland analyst Greg… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly AYRWF Ayr Wellness $4.40 / -0.13675 (-3.01%) 08/16/22 Ayr Wellness launches LEVIA-branded water-soluble tinctures in Nevada, Arizona 08/11/22 Ayr Wellness receives regulatory approval for adult-use sales in Somerville, MA 08/11/22 Ayr Wellness opens 50th retail store in Florida 08/04/22 Ayr Wellness expands cannabis brand LIT to Massachusetts AYRWF Ayr Wellness $4.40 / -0.13675 (-3.01%) 06:18 Today Canaccord Ayr Wellness price target lowered to C$30 from C$40 at Canaccord 07/22/22 Seaport Global Ayr Wellness initiated with a Buy at Seaport Global 03/18/22 Canaccord Ayr Wellness price target lowered to C$40 from C$57 at Canaccord 03/03/22 Needham Ayr Wellness price target lowered to $28 from $35 at Needham AYRWF Ayr Wellness $4.40 / -0.13675 (-3.01%) 08/18/22 Ayr Wellness sees revenue growing 10% sequentially from Q2 to Q3 08/18/22 Ayr Wellness Q2 EPS (56c) vs. (36c) last year 05/26/22 Ayr Wellness sees 4Q22 revenue $800M 05/26/22 Ayr Wellness reports Q1 EPS (11c) vs. (38c) last year AYRWF Ayr Wellness $4.40 / -0.13675 (-3.01%) 08/18/22 Here's What You Missed in Cannabis This Week 06/16/22 Here's What You Missed in Cannabis This Week

Hot Stocks	GI Alliance announces physician-led buyout valuing company at $2.2B » 08:07 08/19/22 08/19 08:07 08/19/22 08:07 APO Apollo Global $59.55 / +0.31 (+0.52%) GI Alliance, has… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events APO Apollo Global $59.55 / +0.31 (+0.52%) 08/11/22 Apollo Global closes $2.35B in commitments to Apollo Origination Fund I 08/04/22 Apollo Global, Belstar to form private credit joint venture in Korea 08/04/22 Atlas Air to be acquired by investor group for $5.2B 08/01/22 Apollo Global publishes 13th annual ESG report APO Apollo Global $59.55 / +0.31 (+0.52%) 08/12/22 Deutsche Bank Apollo Global price target lowered to $87 from $91 at Deutsche Bank 08/05/22 Deutsche Bank Apollo Global price target raised to $91 from $88 at Deutsche Bank 08/03/22 Stifel Atlas Air downgraded to Hold from Buy at Stifel 08/03/22 Wolfe Research Atlas Air upgraded to Peer Perform from Underperform at Wolfe Research APO Apollo Global $59.55 / +0.31 (+0.52%) 08/04/22 Apollo Global reports Q2 adjusted EPS 94c, consensus $1.02 08/03/22 Notable companies reporting before tomorrow's open 08/03/22 Notable companies reporting before tomorrow's open 05/05/22 Apollo Global reports Q1 adjusted EPS $1.52, consensus $1.03 APO Apollo Global $59.55 / +0.31 (+0.52%) 08/17/22 Apollo in talks to acquire minority stake in Manchester United, Daily Mail says 08/03/22 Atlas Air near deal to be acquired for $102.50 per share, Bloomberg says 08/01/22 Apollo-led group in late-stage takes to buy Atlas Air, WSJ reports 08/01/22 Apollo-led group in advanced talks to acquire Atlas Air, WSJ reports APO Apollo Global $59.55 / +0.31 (+0.52%) 08/18/22 What You Missed On Wall Street On Thursday 08/18/22 What You Missed On Wall Street This Morning 08/03/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 08/03/22 Fly Intel: Pre-market Movers 10/07/22 Apollo Global Management Inc
Recommendations	Evolent Health price target raised to $52 from $37 at JPMorgan » 08:07 08/19/22 08/19 08:07 08/19/22 08:07 EVH Evolent Health $34.96 / +0.495 (+1.44%) JPMorgan analyst Anne… JPMorgan analyst Anne Samuel raised the firm's price target on Evolent Health to $52 from $37 and keeps an Overweight rating on the shares. Evolent has announced 10 partnerships year-to-date, which is well above its target for 6-8, Samuel tells investors in a research note. The analyst now sees 24% revenue growth for next year, above the company's mid-teens target, with EBITDA margins of 9%-10%, versus its long-term mid-teens target. However, she sees upside to her analysis, noting we are only halfway through the year, with the company likely to add incremental pa1tnerships. ShowHide Related Items >><< Company News Street Research Earnings On The Fly EVH Evolent Health $34.96 / +0.495 (+1.44%) 06/29/22 Evolent Health to acquire IPG from TPG for $375M in cash 03/07/22 Evolent Health expects to continue provision of services to Cook County Health 02/24/22 Evolent Health rises 16.3% EVH Evolent Health $34.96 / +0.495 (+1.44%) 08/03/22 Canaccord Evolent Health price target raised to $55 from $45 at Canaccord 08/03/22 BTIG Evolent Health price target raised to $50 from $45 at BTIG 08/03/22 Piper Sandler Evolent Health price target raised to $40 from $35 at Piper Sandler 07/28/22 RBC Capital Evolent Health initiated with an Outperform at RBC Capital EVH Evolent Health $34.96 / +0.495 (+1.44%) 08/02/22 Evolent Health sees FY22 revenue $1.32B-$1.36B, consensus $1.22B 08/02/22 Evolent Health sees Q3 revenue $343.0M-$363.0M, consensus $312.69M 08/02/22 Evolent Health reports Q2 adjusted EPS 10c, consensus 5c 05/04/22 Evolent Health sees 2022 revenue $1.16B-$1.21B, consensus $1.16B EVH Evolent Health $34.96 / +0.495 (+1.44%) 07/29/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
Earnings	Ostin Technology reports 1H EPS 11c vs. 14c last year » 08:05 08/19/22 08/19 08:05 08/19/22 08:05 OST Ostin Technology $2.30 / -0.015 (-0.65%) Reports 1H revenue $60.9M… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News OST Ostin Technology $2.30 / -0.015 (-0.65%) 07/28/22 Ostin Technology secures RMB 17.64M LCD/TP display modules order 06/22/22 Ostin begins delivery of large display module orders to Sichuan AI-Chance Tec 04/28/22 OST Stock trading resumes 04/28/22 OST Stock trading halted, volatility trading pause
Conference/Events	Elevance Health management to meet with Stephens » 08:05 08/19/22 08/19 08:05 08/19/22 08:05 ELV Elevance Health $491.62 / +0.91 (+0.19%) Meeting to be held in… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events ELV Elevance Health $491.62 / +0.91 (+0.19%) 08/02/22 Pegasystems names Dr. Kikelomo Belizaire as Chief Medical Officer 08/02/22 Elevance Health, Aledade team on consumer experience for primary care practices 07/20/22 Elevance Health falls -6.3% 07/20/22 Elevance Health reports Q2 operating cash flow $2.5B ELV Elevance Health $491.62 / +0.91 (+0.19%) 07/28/22 Wells Fargo Elevance Health price target lowered to $557 from $580 at Wells Fargo 07/22/22 SVB Securities Elevance Health price target lowered to $490 from $555 at SVB Securities 07/21/22 RBC Capital Elevance Health price target lowered to $505 from $544 at RBC Capital 07/07/22 BTIG 1Life Healthcare upgraded to Buy from Neutral at BTIG ELV Elevance Health $491.62 / +0.91 (+0.19%) 07/20/22 Elevance Health sees FY22 adjusted EPS 'greater than' $28.70, consensus $28.64 07/20/22 Elevance Health reports Q2 adjusted EPS $8.04, consensus $7.74 ELV Elevance Health $491.62 / +0.91 (+0.19%) 08/18/22 White House plans for end of COVID-19 vaccine coverage, WSJ reports ELV Elevance Health $491.62 / +0.91 (+0.19%) 08/18/22 COVID vaccine makers under pressure as White House plans to end coverage 08:00 Today Elevance Health
Hot Stocks	Presbyterian Villages of Michigan, April Housing announce agreement » 08:05 08/19/22 08/19 08:05 08/19/22 08:05 BX Blackstone $107.23 / +0.69 (+0.65%) Presbyterian Villages of… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options BX Blackstone $107.23 / +0.69 (+0.65%) 08/04/22 American Campus stockholders approve acquisition by Blackstone Funds 07/20/22 Coca-Cola Consolidated to replace PS Business Parks in S&P 400 at open on 7/20 07/19/22 Blackstone, Hudson Pacific get approval to develop Sunset Waltham Cross Studios 07/15/22 PS Business Parks holders approve takeover by Blackstone Real Estate affiliates BX Blackstone $107.23 / +0.69 (+0.65%) 08/12/22 Deutsche Bank Blackstone price target raised to $153 from $147 at Deutsche Bank 07/25/22 Piper Sandler Blackstone price target lowered to $120 from $154 at Piper Sandler 07/24/22 Keefe Bruyette Blackstone downgraded to Market Perform from Outperform at Keefe Bruyette 07/22/22 Deutsche Bank Blackstone selloff provides good entry point, says Deutsche Bank BX Blackstone $107.23 / +0.69 (+0.65%) 07/21/22 Blackstone reports Q2 distributable EPS $1.49, consensus $1.44 07/20/22 Notable companies reporting before tomorrow's open 07/20/22 Notable companies reporting before tomorrow's open 08 Dec BX Blackstone $107.23 / +0.69 (+0.65%) 08/17/22 Blackstone looks to raise $400M in Sona Comstar stake sale, Bloomberg says 08/10/22 Blackstone to acquire majority stake in CoreTrust, Bloomberg says 07/06/22 Blackstone to invest $400M in trading platform Xpansiv, WSJ reports 07/05/22 Apollo, Blackstone seek buyers for Ridgeback Resources, Reuters reports BX Blackstone $107.23 / +0.69 (+0.65%) 08/17/22 What You Missed On Wall Street On Wednesday 08/17/22 What You Missed On Wall Street This Morning 07/21/22 What You Missed On Wall Street On Thursday 07/21/22 What You Missed On Wall Street This Morning 09/29/22 Blackstone BX Blackstone $107.23 / +0.69 (+0.65%) 07/26/22 Blackstone call volume above normal and directionally bullish 07/21/22 Unusually active option classes on open July 21st 06/28/22 Blackstone put volume heavy and directionally bearish 06/16/22 Blackstone put volume heavy and directionally bearish
Recommendations	Buy Celsius Holdings on stock weakness, says Jefferies » 08:05 08/19/22 08/19 08:05 08/19/22 08:05 CELH Celsius Holdings $102.86 / +3.87 (+3.91%) Jefferies analyst Kevin… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options CELH Celsius Holdings $102.86 / +3.87 (+3.91%) 08/10/22 Celsius Holdings to replace American Campus in S&P 400 at open on 8/10 08/10/22 Clearfield to replace Celsius Holdings in S&P 600 at open on 8/10 08/04/22 Clearfield to replace Celsius Holdings in S&P 600 at open on 8/10 08/04/22 Celsius Holdings to replace American Campus in S&P 400 at open on 8/10 CELH Celsius Holdings $102.86 / +3.87 (+3.91%) 08/11/22 UBS Celsius Holdings price target raised to $123 from $74 at UBS 08/10/22 B. Riley Celsius Holdings price target raised to $130 from $112 at B. Riley 08/08/22 Jefferies Jefferies predicts strong 'beat and raise' coming from Celsius Holdings 08/02/22 Stifel Celsius Holdings price target raised to $115 from $93 at Stifel CELH Celsius Holdings $102.86 / +3.87 (+3.91%) 08/09/22 Celsius Holdings reports Q2 EPS 12c, consensus 8c 05/10/22 Celsius Holdings reports Q1 EPS 9c, consensus 3c 03/01/22 Celsius Holdings reports preliminary Q4 EPS 15c, consensus 4c 03/01/22 Celsius Holdings reports preliminary Q4 revenue $104.3M, consensus $92.09M CELH Celsius Holdings $102.86 / +3.87 (+3.91%) 08/01/22 What You Missed On Wall Street On Monday 08/01/22 What You Missed On Wall Street This Morning 08/01/22 Fly Intel: Pre-market Movers 06/23/22 What You Missed On Wall Street On Thursday CELH Celsius Holdings $102.86 / +3.87 (+3.91%) 05/10/22 Celsius Holdings options imply 14.8% move in share price post-earnings 03/01/22 Celsius Holdings options imply 14.0% move in share price post-earnings
Hot Stocks	Catalyst Biosciences announces dismissal of JDS1 litigation » 08:04 08/19/22 08/19 08:04 08/19/22 08:04 CBIO Catalyst Biosciences $1.94 / +0.02 (+1.04%) Catalyst Biosciences… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options CBIO Catalyst Biosciences $1.94 / +0.02 (+1.04%) 08/10/22 Catalyst Biosciences announces withdrawal of JDS1 nominatons 08/03/22 Catalyst announces ISS, Glass Lewis recommend shareholders vote FOR nominees 08/01/22 Catalyst Biosciences urges shareholders to vote for Catalyst nominees 08/01/22 Catalyst Biosciences says JEC agrees to vote in favor of Catalyst's nominees CBIO Catalyst Biosciences $1.94 / +0.02 (+1.04%) 05/23/22 Piper Sandler Piper Sandler remains bullish on Catalyst after sale of complement portfolio 03/31/22 Piper Sandler Piper says 'stick it out' with Catalyst Biosciences exploring options 11/12/21 JonesTrading Catalyst Biosciences downgraded to Hold from Buy at JonesTrading 11/12/21 Piper Sandler Catalyst Biosciences price target lowered to $4 from $16 at Piper Sandler CBIO Catalyst Biosciences $1.94 / +0.02 (+1.04%) 05/09/22 Catalyst Biosciences reports Q1 EPS (46c), consensus (44c) 03/31/22 Catalyst Biosciences reports Q4 EPS (65c), consensus (59c) CBIO Catalyst Biosciences $1.94 / +0.02 (+1.04%) 05/09/22 What You Missed On Wall Street This Morning CBIO Catalyst Biosciences $1.94 / +0.02 (+1.04%) 07/25/22 Largest borrow rate increases among liquid names 07/01/22 Unusually active option classes on open July 1st 05/23/22 Unusually active option classes on open May 23rd
Recommendations	Jefferies concerned about potential Keurig acquisition of Vital » 08:04 08/19/22 08/19 08:04 08/19/22 08:04 KDP Keurig Dr Pepper $40.03 / -0.03 (-0.07%) , PEP PepsiCo $180.36 / +0.09 (+0.05%) After Bloomberg reported… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options KDP PEP KDP Keurig Dr Pepper $40.03 / -0.03 (-0.07%) 07/27/22 Keurig Dr Pepper and BLK & Bold Coffee announce new K-Cup pod partnership 07/19/22 Keurig Dr Pepper names George Lagoudakis as interim CFO 07/19/22 Keurig Dr Pepper names Andrew Archambault as president, Commercial 07/19/22 Keurig Dr Pepper: Cold Beverages President Derek Hopkins to leave company PEP PepsiCo $180.36 / +0.09 (+0.05%) 08/10/22 Target elects Grace Puma to board of directors 08/02/22 PepsiCo to take 20% stake in Aqua Carpatica 08/01/22 Celsius announces long-term strategic distribution pact, investment from PepsiCo 08/01/22 PepsiCo to make investment in Celsius Holdings as part of distribution agreement KDP PEP KDP Keurig Dr Pepper $40.03 / -0.03 (-0.07%) 05:52 Today Bernstein Keurig Dr Pepper may get Vital 'on the cheap,' says Bernstein 07/20/22 JPMorgan Keurig Dr Pepper price target lowered to $42 from $44 at JPMorgan 06/21/22 UBS Keurig Dr Pepper downgraded to Neutral from Buy at UBS 03/22/22 Truist Truist cuts Keurig Dr Pepper to Hold on slowdown in coffee segment post-pandemic PEP PepsiCo $180.36 / +0.09 (+0.05%) 08/02/22 Stifel Celsius Holdings price target raised to $115 from $93 at Stifel 08/02/22 B. Riley Celsius Holdings price target raised to $112 from $100 at B. Riley 08/01/22 Morgan Stanley Celsius deal presents limited risk for PepsiCo, says Morgan Stanley 08/01/22 Stifel PepsiCo agreement 'a significant positive' for Celsius, says Stifel KDP PEP KDP Keurig Dr Pepper $40.03 / -0.03 (-0.07%) 07/28/22 Keurig Dr Pepper backs FY22 adj. EPS up mid-single-digit range, consensus $1.69 07/28/22 Keurig Dr Pepper reports Q2 adjusted EPS 39c, consensus 39c 07/27/22 Notable companies reporting before tomorrow's open 07/27/22 Notable companies reporting before tomorrow's open PEP PepsiCo $180.36 / +0.09 (+0.05%) 07/12/22 PepsiCo backs FY22 core EPS view $6.63, consensus $6.66 07/12/22 PepsiCo reports Q2 core EPS $1.86, consensus $1.74 07/11/22 Notable companies reporting before tomorrow's open 04/26/22 PepsiCo cuts FY22 core EPS view to $6.63 from $6.67, consensus $6.65 KDP PEP KDP Keurig Dr Pepper $40.03 / -0.03 (-0.07%) 08/18/22 Keurig in talks to acquire maker of Bang Energy drinks, Bloomberg says 08/18/22 Keurig in talks to acquire maker of Bang Energy drinks, Bloomberg says 08/18/22 Keurig Dr Pepper in talks to acquire Bang Energy maker VPX, Bloomberg says 04/05/22 Keurig Dr Pepper to promote CFO to CEO, Bloomberg reports PEP PepsiCo $180.36 / +0.09 (+0.05%) 06/06/22 CFOs send letter to Treasury Secretary on foreign tax credit rules, WSJ reports 04/14/22 Mondelez, Nestle, Pepsi face criticism from staff over Russia, Reuters reports 03/08/22 PepsiCo suspends sale of Pepsi-Cola, other drinks in Russia, Bloomberg says 03/08/22 PepsiCo exploring write off, other options for Russian business, WSJ reports KDP PEP KDP Keurig Dr Pepper $40.03 / -0.03 (-0.07%) 07/25/22 Fly Insider: CrossFirst Bankshares, Canoo among week's notable insider trades 07/18/22 Fly Insider: Stitch Fix, Arcutis Bio among week's notable insider trades 06/21/22 What You Missed On Wall Street On Tuesday 06/21/22 What You Missed On Wall Street This Morning PEP PepsiCo $180.36 / +0.09 (+0.05%) 08/01/22 What You Missed On Wall Street On Monday 08/01/22 What You Missed On Wall Street This Morning 08/01/22 Fly Intel: Pre-market Movers 07/12/22 What You Missed On Wall Street On Tuesday 09/19/22 Groceryshop 10/12/22 PepsiCo - PEP KDP PEP KDP Keurig Dr Pepper $40.03 / -0.03 (-0.07%) 06/06/22 Unusually active option classes on open June 6th PEP PepsiCo $180.36 / +0.09 (+0.05%) 07/11/22 PepsiCo options imply 2.3% move in share price post-earnings 06/13/22 PepsiCo call volume above normal and directionally bullish 06/01/22 PepsiCo call volume above normal and directionally bullish 04/25/22 PepsiCo options imply 2.3% move in share price post-earnings
Hot Stocks	KB Home announces opening of The Reserves » 08:04 08/19/22 08/19 08:04 08/19/22 08:04 KBH KB Home $32.08 / -0.02 (-0.06%) KB Home announced the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options KBH KB Home $32.08 / -0.02 (-0.06%) 07/29/22 KB Home opens two new-home communities in California 07/29/22 KB Home announces opening of The Traditions at Marbella Ranch in Arizona 06/24/22 KB Home announces grand opening of Orchid in Torrance, California 06/22/22 KB Home jumps 4% to $27.75 after Q2 earnings beat KBH KB Home $32.08 / -0.02 (-0.06%) 07/11/22 Credit Suisse KB Home downgraded to Neutral from Outperform at Credit Suisse 07/11/22 Credit Suisse KB Home downgraded to Neutral from Outperform at Credit Suisse 06/29/22 Raymond James KB Home price target lowered to $44 from $63 at Raymond James 06/23/22 Evercore ISI KB Home price target raised to $50 from $46 at Evercore ISI KBH KB Home $32.08 / -0.02 (-0.06%) 06/22/22 KB Home reports Q2 EPS $2.32, consensus $2.01 06/22/22 Notable companies reporting after market close 03/23/22 KB Home sees FY22 housing revenue $7.2B-$7.6B 03/23/22 KB Home reports Q1 EPS $1.47, consensus $1.56 KBH KB Home $32.08 / -0.02 (-0.06%) 04/14/22 Mortgage rates spike to 5% amid post-pandemic price pressures, NY Times says KBH KB Home $32.08 / -0.02 (-0.06%) 06/23/22 What You Missed On Wall Street On Thursday 06/23/22 What You Missed On Wall Street This Morning 06/23/22 Fly Intel: Pre-market Movers 06/22/22 Fly Intel: After-Hours Movers KBH KB Home $32.08 / -0.02 (-0.06%) 08/02/22 KB Home put volume heavy and directionally bearish 06/22/22 KB Home options imply 6.9% move in share price post-earnings 05/24/22 KB Home put volume heavy and directionally bearish 05/11/22 KB Home put volume heavy and directionally bearish
Hot Stocks	VirTra COO Matt Burlend departs » 08:03 08/19/22 08/19 08:03 08/19/22 08:03 VTSI VirTra $5.05 / +0.2 (+4.12%) Effective August 16,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events VTSI VirTra $5.05 / +0.2 (+4.12%) 08/18/22 VirTra receives C$1.2M follow on order from Canada law enforcement agency 07/18/22 VirTra receives ongoing service agreement from FLETC 06/10/22 VirTra granted listing extension by Nasdaq 05/19/22 VirTra receives notice of non-compliance from Nasdaq VTSI VirTra $5.05 / +0.2 (+4.12%) 11/16/21 Maxim VirTra upgraded to Buy at Maxim on strength in orders and backlog 11/16/21 Maxim VirTra upgraded to Buy from Hold at Maxim VTSI VirTra $5.05 / +0.2 (+4.12%) 08:02 Today VirTra reports Q2 EPS 7c vs. 5c last yeear 10:00 Today VirTra - VTSI

Hot Stocks	Acorda Therapeutics announces resignation of COO » 08:03 08/19/22 08/19 08:03 08/19/22 08:03 ACOR Acorda Therapeutics / + Acorda Therapeutics… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Earnings ACOR Acorda Therapeutics / + 06/16/22 Acorda Therapeutics: Esteve debuts NBRIJA 33mg in Germany for Parkinson's 05/11/22 Acorda Therapeutics, Biopas agree to commercialize INBRIJA in Latin America ACOR Acorda Therapeutics / + 08/04/22 Acorda Therapeutics reports Q2 EPS ($2.78) vs. ($2.29) last year 05/11/22 Acorda Therapeutics reports Q1 EPS ($1.66) vs. ($2.46) last year
Downgrade	Palisade Bio downgraded to Hold from Buy at Maxim » 08:03 08/19/22 08/19 08:03 08/19/22 08:03 PALI Palisade Bio / + Maxim analyst Naz Rahman… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings PALI Palisade Bio / + 08/17/22 Palisade Bio announces first patient enrolled, dosed in Phase 3 study of LB1148 08/12/22 Palisade Bio prices $12M upsized underwritten public offering 08/01/22 Palisade Bio launches new corporate website 07/27/22 Palisade Bio announces first patient screened in Phase 2 study on LB1148 PALI Palisade Bio / + 02/02/22 Ladenburg Palisade Bio initiated with a Buy at Ladenburg 08/31/21 Maxim Palisade Bio initiated with a Buy at Maxim 08/31/21 Maxim Palisade Bio initiated with a Buy at Maxim PALI Palisade Bio / + 08/15/22 Palisade Bio reports Q2 EPS (12c) vs ($4.10) last year 05/13/22 Palisade Bio reports Q1 EPS (26c) vs ($1.45) last year 03/18/22 Palisade Bio reports 2021 EPS ($3.39) vs ($3.72) last year
Hot Stocks	Bowman Consulting names Mullenix EVP, CIO, CISO » 08:02 08/19/22 08/19 08:02 08/19/22 08:02 BWMN Bowman Consulting $15.69 / -0.31 (-1.94%) , VSEC VSE Corp. $46.94 / +2.64 (+5.96%) Bowman Consulting (BWMN)… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly BWMN VSEC BWMN Bowman Consulting $15.69 / -0.31 (-1.94%) 08/16/22 Bowman Consulting awarded $2M contract by Forest Preserves 08/05/22 Bowman Consulting awarded $1.2B IDOT project 07/18/22 Bowman Consulting acquires Project Design Consultants 06/21/22 Bowman Consulting awarded $15.9M contract VSEC VSE Corp. $46.94 / +2.64 (+5.96%) 03/09/22 VSE Corp. awarded $100M NAVSEA contract BWMN VSEC BWMN Bowman Consulting $15.69 / -0.31 (-1.94%) 08/15/22 B. Riley Bowman Consulting price target raised to $27 from $23 at B. Riley 06/28/22 B. Riley Bowman Consulting added to '25 for 22 List' at B. Riley 03/23/22 B. Riley Bowman Consulting price target raised to $26 from $25 at B. Riley 01/06/22 DA Davidson Bowman Consulting price target raised to $26 from $23 at DA Davidson VSEC VSE Corp. $46.94 / +2.64 (+5.96%) 07/19/22 Truist VSE Corp. price target lowered to $55 from $65 at Truist 07/06/22 Canaccord VSE Corp. price target lowered to $50 from $64 at Canaccord 05/18/22 RBC Capital RBC Capital cuts VSE Corp. to Sector Perform, sees limited margin upside 05/18/22 RBC Capital VSE Corp. downgraded to Sector Perform from Outperform at RBC Capital BWMN VSEC BWMN Bowman Consulting $15.69 / -0.31 (-1.94%) 05/11/22 Bowman Consulting raises 2022 billing, EBITDA outlooks 05/11/22 Bowman Consulting reports Q1 EPS 12c, consensus (3c) VSEC VSE Corp. $46.94 / +2.64 (+5.96%) 07/27/22 VSE Corp. reports Q2 adjusted EPS 75c, consensus 61c 04/27/22 VSE Corp. reports Q1 EPS 72c, consensus 54c 03/09/22 VSE Corp. reports Q4 adjusted EPS 53c, consensus 78c 09 Feb VSEC VSEC VSE Corp. $46.94 / +2.64 (+5.96%) 05/18/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
Earnings	VirTra reports Q2 EPS 7c vs. 5c last yeear » 08:02 08/19/22 08/19 08:02 08/19/22 08:02 VTSI VirTra $5.05 / +0.2 (+4.12%) Reports Q2 revenue $8M… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Events VTSI VirTra $5.05 / +0.2 (+4.12%) 08/18/22 VirTra receives C$1.2M follow on order from Canada law enforcement agency 07/18/22 VirTra receives ongoing service agreement from FLETC 06/10/22 VirTra granted listing extension by Nasdaq 05/19/22 VirTra receives notice of non-compliance from Nasdaq VTSI VirTra $5.05 / +0.2 (+4.12%) 11/16/21 Maxim VirTra upgraded to Buy at Maxim on strength in orders and backlog 11/16/21 Maxim VirTra upgraded to Buy from Hold at Maxim 10:00 Today VirTra - VTSI
Conference/Events	LendingTree management to meet with Stephens » 08:02 08/19/22 08/19 08:02 08/19/22 08:02 TREE LendingTree $42.15 / -0.93 (-2.16%) Meetings to be held on… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events TREE LendingTree $42.15 / -0.93 (-2.16%) 03/15/22 EarnUp closes $31M Series C funding round TREE LendingTree $42.15 / -0.93 (-2.16%) 07/29/22 Truist LendingTree price target lowered to $80 from $130 at Truist 07/29/22 Susquehanna LendingTree price target lowered to $59 from $160 at Susquehanna 07/29/22 Oppenheimer LendingTree price target lowered to $55 from $120 at Oppenheimer 06/24/22 Truist LendingTree price target lowered to $130 from $185 at Truist TREE LendingTree $42.15 / -0.93 (-2.16%) 07/28/22 LendingTree cuts FY22 revenue view to $985M-$1.015B from $1.15B-$1.19B 07/28/22 LendingTree sees Q3 revenue $235M-$245M, consensus $294.81M 07/28/22 LendingTree reports Q2 adjusted EPS 58c, consensus 34c 06/23/22 LendingTree cuts Q2 revenue view to $259M-$264M from $283M-$293M TREE LendingTree $42.15 / -0.93 (-2.16%) 06/24/22 What You Missed On Wall Street On Friday 06/24/22 What You Missed On Wall Street This Morning 06/24/22 Fly Intel: Pre-market Movers 06/23/22 Fly Intel: After-Hours Movers 00:00 Today LendingTree

Events

Earnings calls, analyst events, roadshows and more

RNW
Today at 08:30

ReNew Energy Global - RNW Conference Calls
VJET
Today at 08:30

Voxeljet - VJET Conference Calls
FL
Today at 09:00

Foot Locker - FL Conference Calls
IGIC
Today at 09:00

International General Insurance - IGIC Conference Calls
KAL
Today at 09:00

Kalera - KAL Conference Calls
NVGS
Today at 09:00

Navigator Holdings - NVGS Conference Calls
NMRD
Today at 09:00

Nemaura Medical Inc. Firm Sponsored Meetings
ALJJ
Today at 09:00

ALJ Regional Holdings Inc. Firm Sponsored Meetings

599 Lexington Ave, New York, NY
Today at 10:00

Quarterly Services Survey: Information Revenue Y/Y: Q2(a):2022 Government Event
Today at 10:00

Quarterly Services Survey: Information Revenue Q/Q: Q2(a):2022 Government Event

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	BROS X BROS Dutch Bros Block Trade Managers: Morgan Stanley Priced at: $43.50 5.97M Shares GRFX X GRFX Graphex Group IPO Managers: EF Hutton Priced at: $2.50 4.7M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial LUCY X LUCY Innovative Eyewear IPO Managers: Maxim Priced at: $7.50 980K Shares SVFD X SVFD Save Foods Secondary Managers: ThinkEquity Priced at: $3.00 1.6M Shares FULC X FULC Fulcrum Therapeutics Spot Secondary Managers: Goldman Sachs & SVB Securities, Stifel, Oppenheimer Priced at: $7.82 9.591M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial TELA X TELA Tela Bio Spot Secondary Managers: Lake Street Priced at: $8.00 4M Shares TRIN X TRIN Trinity Capital Spot Secondary Managers: Keefe Bruyette, Morgan Stanley, UBS & Wells Fargo Priced at: $15.33 3.6M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	BE X BE Bloom Energy Secondary Managers: JPMorgan, Morgan Stanley & BofA Priced at: $26.00 13M Shares VRDN X VRDN Viridian Therapeutics Secondary Managers: Jefferies, SVB Securities & Evercore ISI Priced at: $23.50 9.628M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ASLE X ASLE AerSale Spot Secondary Managers: Cowen, RBC Capital & Stifel, Truist Priced at: $17.25 4.25M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial OPCH X OPCH Option Care Health Spot Secondary Managers: Goldman Sachs Priced at: $33.25 11M Shares OSH X OSH Oak Street Health Spot Secondary Managers: JPMorgan, Goldman Sachs, Morgan Stanley, William Blair & Piper Sandler Priced at: $25.75 7M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	GCT X GCT GigaCloud IPO Managers: Aegis Priced at: $12.25 29.04M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial GFRX X GFRX Graphex Group Secondary Managers: EF Hutton Priced at: $2.50 4.7M Shares UBX X UBX Unity Biotechnology Secondary Managers: SVB Securities, Cantor Fitzgerald & Mizuho, Wedbush Priced at: $.70 64.3M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	AXDX X AXDX Accelerate Diagnostics Secondary Managers: William Blair, Oppenheimer, Craig-Hallum Priced at: $2.00 17.5M Shares CGRN X CGRN Capstone Green Energy Spot Secondary Managers: Lake Street, Joseph Gunnar Priced at: $2.75 2.9M Shares
Fri	No deals

Mon	DVAX X DVAX Dynavax Block Trade Managers: Goldman Sachs $14.85-15.62 3M Shares
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

View All Syndicate Announcements »

PPL Corp. upgraded to Outperform at Evercore ISI with re-rating expected

OTHER BREAKING NEWS FROM THE FLY

Get Full Fly Access